Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Foamix Pharmaceuticals First Quarter 2019 Financial Results Conference Call & Webcast Scheduled for May 8 | ||||||||||||||||||||||||||
| By: Nasdaq / GlobeNewswire - 24 Apr 2019 | Back to overview list |
|||||||||||||||||||||||||
REHOVOT, Israel and BRIDGEWATER, N.J., April 24, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, today announced that it will report its financial results for the first quarter ended March 31, 2019, on Tuesday, May 7, after the markets close. Foamix will host a conference call and webcast at 8:30 a.m. Eastern Time on Wednesday, May 8.
A replay of the call will be archived on the Company’s website at www.foamix.com promptly after the conference call. About Foamix Foamix uses its website (www.Foamix.com) as a channel to distribute information about Foamix and its product candidates from time to time. Foamix may use its website to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Foamix’s website in addition to following its press releases, filings with the Securities & Exchange Commission, public conference calls, and webcasts. Contact: U.S. Investor Relations |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
 | Back to overview list | |||||||||||||||||||||||||